G7 Platform for Net-zero and
Well-being in Life

Reduced cleanroom ventilation rates

United States
USA Genentech / F. Hoffmann-La Roche Inc., global project
Case study of USA
Genentech / F. Hoffmann-La Roche Inc., global project

F. Hoffmann-La Roche Inc. (Roche; www.roche.com) recognizes that the ventilation rates needed to ensure cleanroom manufacturing environmental standards can result in high energy intensity, and are thus a focus of optimization across the enterprise. To improve the energy efficiency of its cleanrooms, the manufacturing site in Oceanside, California USA operated by Roche's Genentech subsidiary collaborated with the Roche Global Engineering team to implement a risk-based approach to achieve lower air changes during operation without adversely impacting the facility, equipment, or reliability, while meeting environmental requirements. The implemented changes reduced air flow volume by 165,000 cfm (cubic feet per minute), resulting in a 14% decrease in energy consumption and GHG emissions for the site, and over $678,000 cost savings per year.

Country

United States

Name of Organization

USA Genentech / F. Hoffmann-La Roche Inc., global project

Further information

July / August 2023 | ISPE | International Society for Pharmaceutical Engineering
https://ispe.org/pharmaceutical-engineering/July-August-2023Open in New Window